| Health care utilization and costs associated with functional status in patients with psoriatic arthritis A Ogdie, M Hwang, P Veeranki, A Portelli, S Sison, J Shafrin, S Pedro, ... Journal of Managed Care & Specialty Pharmacy 28 (9), 997-1007, 2022 | 12 | 2022 |
| Association of health care utilization and costs with patient-reported outcomes in patients with ankylosing spondylitis A Ogdie, M Hwang, P Veeranki, A Portelli, S Sison, J Shafrin, S Pedro, ... Journal of Managed Care & Specialty Pharmacy 28 (9), 1008-1020, 2022 | 9 | 2022 |
| Estimating the impact of biosimilar entry on prices and expenditures in rheumatoid arthritis: a case study of targeted immune modulators EJ Maksabedian Hernandez, M Graf, A Portelli, J Shafrin Journal of medical economics 25 (1), 1118-1126, 2022 | 7 | 2022 |
| Patient and physician perspectives guiding intra-articular treatment choice in knee osteoarthritis: stakeholders are aligned on treatment priorities but have different … V Menon, C Huber, A Portelli, M Baker-Wagner, S Kelley, K Lang Journal of ISAKOS 6 (5), 271-276, 2021 | 4 | 2021 |
| P154 Indirect comparison of exacerbation rates among patients treated with reslizumab compared to omalizumab and mepolizumab W Mountford, E Kaufman, A Portelli, S Sun Annals of Allergy, Asthma & Immunology 117 (5), S67-S68, 2016 | 1 | 2016 |
| Association of Opioid Use and Opioid-Related Costs with Patient-Reported Outcomes in Patients with Psoriatic Arthritis or Ankylosing Spondylitis A Ogdie-Beatty, M Hwang, P Veeranki, A Portelli, J Shafrin, S Pedro, E Yi, ... ARTHRITIS & RHEUMATOLOGY 73, 3701-3704, 2021 | | 2021 |
| PMS75 PATIENT-AND PHYSICIAN-IDENTIFIED FACTORS GUIDING TREATMENT CHOICE IN KNEE OSTEOARTHRITIS AND PATIENT PREFERENCE FOR INTRA-ARTICULAR THERAPY V Menon, C Huber, M Baker-Wagner, A Portelli, SD Kelley, K Lang Value in Health 23, S228-S229, 2020 | | 2020 |
| PMU94 ASSESSING THE POTENTIAL VALUE OF REAL-TIME DATA MONITORING FROM DIGITAL HEALTH TECHNOLOGIES: INSIGHTS FROM POINT-OF-CARE TECHNOLOGIES A Portelli, D Nayak, H Jin, C Huber Value in Health 23, S250, 2020 | | 2020 |
| Knee osteoarthritis specialists decisions and perceptions regarding treatment selection and patient experiences with intra-articular therapies V Menon, C Huber, M Baker-Wagner, A Portelli, S Kelley, K Lang Osteoarthritis and Cartilage 28, S501-S502, 2020 | | 2020 |
| 157 Clinical Burden of Recurrent Clostridioides difficile Infection: A Real-World Data Analysis L Stong, WW Nelson, P Feuerstadt, M Boules, N Sacks, A Portelli, ... Official journal of the American College of Gastroenterology| ACG 114, S94-S96, 2019 | | 2019 |
| 2374. Healthcare Resource Use, Costs, and Recurrences in Patients with Clostridioides difficile Infection: A Real-world Data Analysis W Nelson, L Stong, N Sacks, A Portelli, B Healey, K Lang, DN Dahdal Open Forum Infectious Diseases 6 (Suppl 2), S819, 2019 | | 2019 |
| The Association of Metformin Exposure and Specific Types of Digestive Cancers Among Diabetic Patients: Real-World Findings from a US EMR Database WK Mountford, E Kaufman, A Portelli, CA Knox PHARMACOEPIDEMIOLOGY AND DRUG SAFETY 25, 541-542, 2016 | | 2016 |
| Indirect Comparison of Exacerbation Rates Among Patients Treated With Reslizumab Compared to Omalizumab and Mepolizumab Friday/4: 40 PM/Monitor 8 W Mountford, E Kaufman, A Portelli, S Sun | | |
